Evidence map›Paper›PMID 26224549›Full record

ReviewNPJ primary care respiratory medicine2015

The GINA asthma strategy report: what's new for primary care?

Helen K Reddel, Mark L Levy, Global Initiative for Asthma Scientific Committee and Dissemination and Implementation Committee

Abstract readReview
In one paragraph

Review in NPJ primary care respiratory medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Effects of sublingual immunotherapy for dust mite on Th 17 / Treg cells in children with asthma.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  8. Article
  9. Article
  10. Short-acting βActa medica Philippina · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Care of Asthma Patients in Communities with Limited Resources.Research and reports in tropical medicine · 2021
    Review
  17. Article
  18. Review
  19. Heliyon · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Helen K ReddelClinical Management Group, Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.
Mark L Levy1] Kenton Bridge Medical Centre, Harrow, UK [2] Harrow Clinical Commissioning Group, London, UK.
Global Initiative for Asthma Scientific Committee and Dissemination and Implementation Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Initiative for Asthma (GINA) was established in 1993 by the World Health Organization and National Heart Lung and Blood Institute to develop a global strategy for managing and preventing asthma. GINA reports, now funded independently through the sale of GINA products, have provided the foundation for many national guidelines. They are prepared by international experts from primary, secondary and tertiary care, and are annually updated following a review of evidence. In 2014, a major revision of the GINA report was published, that took into account advances in evidence not only about asthma and its treatment, but also about how to improve implementation of evidence-based recommendations in clinical practice. This paper summarises key changes relevant to primary care in the new GINA report. A noticeable difference is the report's radically different approach, now clinically-focussed, with multiple practical tools and flow charts to improve its utility for busy frontline clinicians. Key changes in recommendations include a new, diagnosis-centred definition of asthma; more detail about how to assess current symptom control and future risk; a comprehensive approach to tailoring treatment for individual patients; expanded indications for commencing inhaled corticosteroids; new recommendations for written asthma action plans; a new chapter on diagnosis and initial treatment of patients with asthma-COPD overlap syndrome; and a revised approach to diagnosing asthma in preschool children. The 2014 GINA report (further updated in 2015) moved away from a 'textbook' approach to provide clinicians with up-to-date evidence about strategies to control symptoms and minimise asthma risk, in a practical, practice-centred format.

Indexed as

Global HealthPrimary Health CareAnti-Asthmatic AgentsAsthmaDisease ManagementHumansWorld Health OrganizationAnti-Asthmatic Agents

Identifiers

PMID26224549
PMCPMC4519996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.